Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Gynecol Oncol. 2009 Apr 8;114(1):57–60. doi: 10.1016/j.ygyno.2009.02.023

Figure 1. Serum MIS/AMH measurements correlate with gross aggregate tumor mass.

Figure 1

Linear regression analysis shows significant direct correlation between patient serum MIS/AMH levels in ng/ml drawn within 3 days before surgery and gross aggregate tumor mass in mm3 as determined by pathology examination of surgical specimens. Each data point represents a separate patient. The dotted lines indicate 95% confidence bands. (slope=15.4±6.06, r=0.65, p<0.04).